Omnicell Inc (OMCL)
29.88
-0.08
(-0.27%)
USD |
NASDAQ |
May 09, 09:43
Omnicell Enterprise Value: 1.422B for May 8, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 08, 2024 | 1.422B |
| May 07, 2024 | 1.438B |
| May 06, 2024 | 1.423B |
| May 03, 2024 | 1.430B |
| May 02, 2024 | 1.391B |
| May 01, 2024 | 1.294B |
| April 30, 2024 | 1.277B |
| April 29, 2024 | 1.304B |
| April 26, 2024 | 1.325B |
| April 25, 2024 | 1.292B |
| April 24, 2024 | 1.306B |
| April 23, 2024 | 1.352B |
| April 22, 2024 | 1.340B |
| April 19, 2024 | 1.324B |
| April 18, 2024 | 1.297B |
| April 17, 2024 | 1.252B |
| April 16, 2024 | 1.270B |
| April 15, 2024 | 1.280B |
| April 12, 2024 | 1.294B |
| April 11, 2024 | 1.301B |
| April 10, 2024 | 1.306B |
| April 09, 2024 | 1.361B |
| April 08, 2024 | 1.327B |
| April 05, 2024 | 1.310B |
| April 04, 2024 | 1.313B |
| Date | Value |
|---|---|
| April 03, 2024 | 1.312B |
| April 02, 2024 | 1.320B |
| April 01, 2024 | 1.361B |
| March 31, 2024 | 1.388B |
| March 28, 2024 | 1.432B |
| March 27, 2024 | 1.433B |
| March 26, 2024 | 1.371B |
| March 25, 2024 | 1.394B |
| March 22, 2024 | 1.372B |
| March 21, 2024 | 1.396B |
| March 20, 2024 | 1.372B |
| March 19, 2024 | 1.359B |
| March 18, 2024 | 1.351B |
| March 15, 2024 | 1.361B |
| March 14, 2024 | 1.357B |
| March 13, 2024 | 1.364B |
| March 12, 2024 | 1.379B |
| March 11, 2024 | 1.388B |
| March 08, 2024 | 1.401B |
| March 07, 2024 | 1.378B |
| March 06, 2024 | 1.366B |
| March 05, 2024 | 1.302B |
| March 04, 2024 | 1.310B |
| March 01, 2024 | 1.300B |
| February 29, 2024 | 1.295B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.252B
Minimum
Apr 17 2024
8.103B
Maximum
Jan 03 2022
3.949B
Average
3.359B
Median
Enterprise Value Benchmarks
| Teladoc Health Inc | 2.511B |
| American Shared Hospital Services | 26.86M |
| Novo Integrated Sciences Inc | 13.02M |
| Astrana Health Inc | 1.487B |
| Cryo-Cell International Inc | 80.39M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.68M |
| Revenue (Quarterly) | 246.15M |
| Total Expenses (Quarterly) | 268.00M |
| EPS Diluted (Quarterly) | -0.34 |
| Gross Profit Margin (Quarterly) | 37.63% |
| Profit Margin (Quarterly) | -6.37% |
| Earnings Yield | -1.54% |
| Normalized Earnings Yield | -1.540 |